For research use only. Not for therapeutic Use.
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling[1].
| Catalog Number | I042414 |
| CAS Number | 2235419-62-0 |
| Purity | ≥95% |
| Reference | [1]. Fernandes JC. Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects. Drug Discov Today. 2018 Dec;23(12):1996-2002. |
